ALKERMES reported 293.44M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Amgen AMGN:US $ 28458M 2671M
Biogen BIIB:US $ 6272.3M 996.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Coherus Biosciences CHRS:US $ 287.08M 11.83M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Gilead Sciences GILD:US $ 27914M 7M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
H. Lundbeck A/S LUN:DC 5.71B 42M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Horizon Pharma HZNP:US $ 2560.44M 2.07M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Merk MRK:US $ 24033M 31M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Otsuka Holdings 4578:JP Y 169463M 10162M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Revance Therapeutics RVNC:US $ 280M 0.31M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Zogenix ZGNX:US $ 153.63M 2.18M